Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMC Samsung Volvo
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 28, 12:49
463.50
1.3 (0.28%)
VOLUME 77,243
LIVE
NSE
Jan 28, 12:50
463.20
1.15 (0.25%)
VOLUME 1,537,878
News on Cadila Healthcare
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Cadila Healthcare; target of Rs 655: Emkay Global Financial

5.01 pm | 25 Jan 2021 |  Source: Moneycontrol.com

Emkay Global Financial is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 655 in its research report da...

Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in Mexico

10.57 am | 25 Jan 2021 |  Source: PTI

In June 2020, Zydus Cadila had received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate Desidustat...

Status check on COVID-19 vaccines in pipeline for India over next six months

8.44 pm | 20 Jan 2021 |  Source: Moneycontrol.com

In the initial phase, India will inoculate about one crore healthcare workers. This will be followed by two crore frontline workers, police, armed for...

Cadila Healthcare Q3 PAT seen up 37.6% YoY to Rs. 373.9 cr: Prabhudas Lilladher

10.52 pm | 18 Jan 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 5.3 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs. 3,638.1 crore, according to Prabhudas Lilladher....

Transported 3.5 tonnes of COVID-19 vaccines to 11 cities on Wednesday: SpiceJet

10.24 pm | 12 Jan 2021 |  Source: PTI

The movement of COVID-19 vaccines began on Tuesday morning. The shots will be used in the vaccination drive beginning Saturday....

Cadila Healthcare shares rise 3% on DCGI nod to Phase III clinical trials of COVID-19 vaccine

9.35 am | 04 Jan 2021 |  Source: Moneycontrol.com

In Phase II, the vaccine ZyCoV-D was found to be safe and elicited a strong immunogenic response....

Zydus Cadila plans to test its COVID-19 vaccine on 30,000 volunteers in late stage trial 

10.15 pm | 24 Dec 2020 |  Source: Moneycontrol.com

Cadila Healthcare said its vaccine was found to be well tolerated and immunogenic in the Phase I/II clinical trials....

Accumulate Cadila Healthcare; target of Rs 497: Dolat Capital Market

6.54 pm | 07 Nov 2020 |  Source: Moneycontrol.com

Dolat Capital Market recommended accumulate rating on Cadila Healthcare with a target price of Rs 497 in its research report dated November 02, 2020....

Buy Cadila Healthcare; target of Rs 555: ICICI Direct

1.41 pm | 07 Nov 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 555 in its research report dated Novemb...

Sell Cadila Healthcare; target of Rs 357: Prabhudas Lilladher

4.45 pm | 06 Nov 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bearish on Cadila Healthcare has recommended sell rating on the stock with a target price of Rs 357 in its research report date...

Buy Cadila Healthcare: target of Rs 530: Sharekhan

5.07 pm | 05 Nov 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 530 in its research report dated November 03, ...

Cadila Health Standalone September 2020 Net Sales at Rs 2,056.90 crore, up 22.24% Y-o-Y

9.22 am | 03 Nov 2020 |  Source: Moneycontrol.com

NULL...

Cadila Health Consolidated September 2020 Net Sales at Rs 3,820.00 crore, up 13.47% Y-o-Y

9.11 am | 03 Nov 2020 |  Source: Moneycontrol.com

NULL...

Cadila: a formidable play in Covid times and beyond

9.39 am | 25 Sep 2020 |  Source: Moneycontrol.com

Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space w...

Reduce Cadila Healthcare; target of Rs 408: Dolat Capital

5.05 pm | 17 Aug 2020 |  Source: Moneycontrol.com

Dolat Capital recommended reduce rating on Cadila Healthcare with a target price of Rs 408 in its research report dated August 14, 2020....

Buy Cadila Healthcare; target of Rs 470: ICICI Direct

1.00 pm | 10 Aug 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 470 in its research report dated August...

Reduce Cadila Healthcare; target of Rs 408: Dolat Capital

9.16 pm | 09 Aug 2020 |  Source: Moneycontrol.com

Dolat Capital recommended accumulate rating on Cadila Healthcare with a target price of Rs 408 in its research report dated August 05, 2020....

Hold Cadila Healthcare; target of Rs 402: Emkay Global Financial

2.43 pm | 08 Aug 2020 |  Source: Moneycontrol.com

Emkay Global Financial recommended hold rating on Cadila Healthcare with a target price of Rs 402 in its research report dated August 05, 2020....

Sell Cadila Healthcare; target of Rs 329: Prabhudas Lilladher

12.34 pm | 08 Aug 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bearish on Cadila Healthcare has recommended sell rating on the stock with a target price of Rs 329 in its research report date...

Hold Cadila Healthcare; target of Rs 445: Sharekhan

2.13 pm | 07 Aug 2020 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 445 in its research report dated August 05, 2020....

1 2
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.